Follow
Kasey Rivas
Kasey Rivas
Research Scientist, University of Washington
Verified email at uw.edu
Title
Cited by
Cited by
Year
Protein farnesyltransferase inhibitors exhibit potent antimalarial activity
L Nallan, KD Bauer, P Bendale, K Rivas, K Yokoyama, CP Hornéy, ...
Journal of medicinal chemistry 48 (11), 3704-3713, 2005
2262005
A noncoding RNA antisense to moesin at 5p14. 1 in autism
T Kerin, A Ramanathan, K Rivas, N Grepo, GA Coetzee, DB Campbell
Science translational medicine 4 (128), 128ra40-128ra40, 2012
1502012
Novel paradigms for drug discovery: computational multitarget screening
E Jenwitheesuk, JA Horst, KL Rivas, WC Van Voorhis, R Samudrala
Trends in pharmacological sciences 29 (2), 62-71, 2008
1482008
A Specific Inhibitor of PfCDPK4 Blocks Malaria Transmission: Chemical-genetic Validation
KK Ojo, RT Eastman, RSR Vidadala, Z Zhang, KL Rivas, R Choi, JD Lutz, ...
The Journal of infectious diseases 209 (2), 275-284, 2014
1012014
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with …
RSR Vidadala, KL Rivas, KK Ojo, MA Hulverson, JA Zambriski, I Bruzual, ...
Journal of medicinal chemistry 59 (13), 6531-6546, 2016
902016
Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials
P Bendale, S Olepu, PK Suryadevara, V Bulbule, K Rivas, L Nallan, ...
Journal of medicinal chemistry 50 (19), 4585-4605, 2007
902007
A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis
A Castellanos-Gonzalez, AC White Jr, KK Ojo, RSR Vidadala, Z Zhang, ...
The Journal of infectious diseases 208 (8), 1342-1348, 2013
812013
Novel bumped kinase inhibitors are safe and effective therapeutics in the calf clinical model for cryptosporidiosis
DA Schaefer, DP Betzer, KD Smith, ZG Millman, HC Michalski, ...
The Journal of infectious diseases 214 (12), 1856-1864, 2016
682016
2-Oxo-tetrahydro-1, 8-naphthyridines as selective inhibitors of malarial protein farnesyltransferase and as anti-malarials
S Olepu, PK Suryadevara, K Rivas, K Yokoyama, CLMJ Verlinde, ...
Bioorganic & medicinal chemistry letters 18 (2), 494-497, 2008
682008
Bumped-kinase inhibitors for cryptosporidiosis therapy
MA Hulverson, S Vinayak, R Choi, DA Schaefer, A Castellanos-Gonzalez, ...
The Journal of infectious diseases 215 (8), 1275-1284, 2017
612017
Potent and Selective Inhibitors of CDPK1 from T. gondii and C. parvum Based on a 5-Aminopyrazole-4-carboxamide Scaffold
Z Zhang, KK Ojo, RSR Vidadala, W Huang, JA Geiger, S Scheele, R Choi, ...
ACS medicinal chemistry letters 5 (1), 40-44, 2014
592014
Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase
MA Hast, S Fletcher, CG Cummings, EE Pusateri, MA Blaskovich, K Rivas, ...
Chemistry & biology 16 (2), 181-192, 2009
582009
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase
SN Hewitt, DM Dranow, BG Horst, JA Abendroth, B Forte, I Hallyburton, ...
ACS infectious diseases 3 (1), 34-44, 2017
562017
Structurally Simple, Potent, Plasmodium Selective Farnesyltransferase Inhibitors That Arrest the Growth of Malaria Parasites
MP Glenn, SY Chang, C Hornéy, K Rivas, K Yokoyama, EE Pusateri, ...
Journal of medicinal chemistry 49 (19), 5710-5727, 2006
532006
Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites
MP Glenn, SY Chang, O Hucke, CLMJ Verlinde, K Rivas, C Hornéy, ...
Angewandte Chemie International Edition 44 (31), 4903-4906, 2005
532005
Potent, Plasmodium-selective farnesyltransferase inhibitors that arrest the growth of malaria parasites: structure− activity relationships of ethylenediamine-analogue scaffolds …
S Fletcher, CG Cummings, K Rivas, WP Katt, C Hornéy, FS Buckner, ...
Journal of medicinal chemistry 51 (17), 5176-5197, 2008
492008
Efficacy, Pharmacokinetics, and Metabolism of Tetrahydroquinoline Inhibitors of Plasmodium falciparum Protein Farnesyltransferase
WC Van Voorhis, KL Rivas, P Bendale, L Nallan, C Hornéy, LK Barrett, ...
Antimicrobial agents and chemotherapy 51 (10), 3659-3671, 2007
482007
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds
GJ Crowther, HK Hillesland, KR Keyloun, MC Reid, ...
PloS one 11 (3), e0149996, 2016
472016
2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability
VJ Bulbule, K Rivas, CLMJ Verlinde, WC Van Voorhis, MH Gelb
Journal of medicinal chemistry 51 (3), 384-387, 2008
442008
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1
W Huang, KK Ojo, Z Zhang, K Rivas, RSR Vidadala, S Scheele, ...
ACS medicinal chemistry letters 6 (12), 1184-1189, 2015
372015
The system can't perform the operation now. Try again later.
Articles 1–20